Literature DB >> 30553706

Individual Operator Experience and Outcomes in Transcatheter Aortic Valve Replacement.

Arash Salemi1, Art Sedrakyan2, Jialin Mao2, Adham Elmously1, Harindra Wijeysundera3, Derrick Y Tam3, Antonino Di Franco1, Simon Redwood4, Leonard N Girardi1, Stephen E Fremes3, Mario Gaudino5.   

Abstract

OBJECTIVES: The aim of this study was to assess the impact of individual operator experience on transfemoral transcatheter aortic valve replacement (TAVR) outcomes.
BACKGROUND: TAVR volume-outcome relationships have not been evaluated at the individual operator level.
METHODS: New York Statewide Planning and Research Cooperative System data from 8,771 transfemoral TAVR procedures performed by 207 operators between 2012 and 2016 were analyzed. Operator volume was defined as the number of TAVR procedures performed during 1 year prior to the index procedure. Hierarchical and restrictive cubic spline regression models were used to evaluate the impact of individual operator experience on risk-adjusted in-hospital outcomes. The primary outcome was a composite of in-hospital mortality, stroke, and/or acute myocardial infarction. Secondary outcomes were the individual components of the primary outcome.
RESULTS: After adjusting for hospital and physician characteristics, patients undergoing TAVR performed by high-volume physicians (≥80/year) had a significantly lower risk for death, stroke, or acute myocardial infarction (odds ratio: 0.59; 95% confidence interval: 0.37 to 0.93) compared with those treated by low-volume physicians (<24/year). Being treated by operators who performed 200 procedures during the prior year was associated with significantly lower risks for post-procedural stroke (odds ratio: 0.41; 95% confidence interval: 0.17 to 0.97) and composite events (odds ratio: 0.45; 95% confidence interval: 0.26 to 0.78). This relationship was nonlinear, and a sensitivity analysis excluding the first 10, 20, and 30 procedures for each operator mitigated the effect of the initial learning curve.
CONCLUSIONS: Increased TAVR experience of operators is associated with improved risk-adjusted in-hospital outcomes. These results have potentially important implications for individual training and hospital programs in TAVR.
Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  New York State; stroke; transcatheter aortic valve replacement; volume-outcome relationship

Year:  2018        PMID: 30553706     DOI: 10.1016/j.jcin.2018.10.030

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  10 in total

Review 1.  A systematic review and meta-analysis of the cerebrovascular event incidence after transcatheter aortic valve implantation.

Authors:  Christian Frerker; Tobias Schmidt; Max M Meertens; Sascha Macherey; Sebastiaan Asselberghs; Samuel Lee; Jan Hendrik Schipper; Barend Mees; Ingo Eitel; Stephan Baldus
Journal:  Clin Res Cardiol       Date:  2022-03-17       Impact factor: 6.138

2.  How Referring Providers Choose Specialists for Their Patients: a Systematic Review.

Authors:  Caitlin B Finn; Jason K Tong; Hannah E Alexander; Chris Wirtalla; Heather Wachtel; Carmen E Guerra; Shivan J Mehta; Richard Wender; Rachel R Kelz
Journal:  J Gen Intern Med       Date:  2022-04-19       Impact factor: 6.473

3.  Trends in Readmission and Costs After Transcatheter Implantation Versus Surgical Aortic Valve Replacement in Patients With Renal Dysfunction.

Authors:  Yas Sanaiha; Aditya Mantha; Boback Ziaeian; Yen-Yi Juo; Richard J Shemin; Peyman Benharash
Journal:  Am J Cardiol       Date:  2019-02-08       Impact factor: 2.778

4.  Real World Performance Evaluation of Transcatheter Aortic Valve Implantation.

Authors:  Gabriele Pesarini; Gabriele Venturi; Domenico Tavella; Leonardo Gottin; Mattia Lunardi; Elena Mirandola; Francesco Onorati; Giuseppe Faggian; Flavio Ribichini
Journal:  J Clin Med       Date:  2021-04-27       Impact factor: 4.241

5.  Clinical outcomes of patients undergoing percutaneous left atrial appendage occlusion in general anaesthesia or conscious sedation: data from the prospective global Amplatzer Amulet Occluder Observational Study.

Authors:  Kerstin Piayda; Katharina Hellhammer; Jens Erik Nielsen-Kudsk; Boris Schmidt; Patrizio Mazzone; Sergio Berti; Sven Fischer; Juha Lund; Matteo Montorfano; Paolo Della Bella; Ryan Gage; Tobias Zeus
Journal:  BMJ Open       Date:  2021-03-24       Impact factor: 2.692

6.  Transapical Transcatheter Aortic Valve Replacement: A Real-World Early and Mid-Term Outcome of a Third-Level Centre.

Authors:  Alessandra Francica; Filippo Tonelli; Alberto Saran; Gabriele Pesarini; Igor Vendramin; Rocco Tabbì; Cecilia Rossetti; Giovanni Battista Luciani; Flavio L Ribichini; Francesco Onorati
Journal:  J Clin Med       Date:  2022-07-18       Impact factor: 4.964

7.  Same-Day Discharge After Transcatheter Aortic Valve Implantation: Insights from the Nationwide Readmission Database 2015 to 2019.

Authors:  Salman Zahid; Devesh Rai; Mian Tanveer Ud Din; Muhammad Zia Khan; Waqas Ullah; Muhammad Usman Khan; Samarthkumar Thakkar; Ahmed Hussein; Bipul Baibhav; Mohan Rao; Farhad Abtahian; Deepak L Bhatt; Jeremiah P Depta
Journal:  J Am Heart Assoc       Date:  2022-05-27       Impact factor: 6.106

Review 8.  Volume-Outcome Relationship in Surgical and Cardiac Transcatheter Interventions with a Focus on Transcatheter Aortic Valve Implantation.

Authors:  Sarah Mauler-Wittwer; Stephane Noble
Journal:  J Clin Med       Date:  2022-06-30       Impact factor: 4.964

9.  Temporal Trends of Transcatheter Aortic Valve Implantation over 12 Years: A High-Volume Single-Center Experience.

Authors:  Shir Frydman; David Zahler; Ilan Merdler; Ophir Freund; Yacov Shacham; Shmuel Banai; Ariel Finkelstein; Arie Steinvil
Journal:  J Clin Med       Date:  2022-08-24       Impact factor: 4.964

10.  Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients.

Authors:  Georg Wolff; Jasmin Shamekhi; Baravan Al-Kassou; Noriaki Tabata; Claudio Parco; Kathrin Klein; Oliver Maier; Alexander Sedaghat; Amin Polzin; Atsushi Sugiura; Christian Jung; Eberhard Grube; Ralf Westenfeld; Andrea Icks; Tobias Zeus; Jan-Malte Sinning; Stephan Baldus; Georg Nickenig; Malte Kelm; Verena Veulemans
Journal:  Clin Res Cardiol       Date:  2020-08-26       Impact factor: 5.460

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.